Summary: Signaling through the Notch1 receptor is essential for the control of numerous developmental processes during embryonic life as well as in adult tissue homeostasis and disease. Since the outcome of Notch1 signaling is highly context-dependent, and its precise physiological and pathological role in many organs is unclear, it is of great interest to localize and identify the cells that receive active Notch1 signals in vivo. Here, we report the generation and characterization of a BAC-transgenic mouse line, N1-Gal4VP16, that when crossed to a Gal4-responsive reporter mouse line allowed the identification of cells undergoing active Notch1 signaling in vivo. Analysis of embryonic and adult N1-Gal4VP16 mice demonstrated that the activation pattern of the transgene coincides with previously observed activation patterns of the endogenous Notch1 receptor. Thus, this novel reporter mouse line provides a unique tool to specifically investigate the spatial and temporal aspects of Notch1 signaling in vivo. genesis 50: [700] [701] [702] [703] [704] [705] [706] [707] [708] [709] [710] 2012 . V V C 2012 Wiley Periodicals, Inc.
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The Notch cascade regulates many cellular differentiation events through cell-to-cell communication in a context-and dose-dependent manner during embryonic and postnatal development. In addition, dysfunctional Notch signaling results in a large variety of developmental defects as well as adult pathologies including cancer (reviewed in Artavanis-Tsakonas and Muskavitch, 2010) . The Notch genes (Notch1-Notch4 in mammals) encode single transmembrane cell surface receptors, which are bound by the Delta and Jagged family members of ligands on neighboring cells. Notch signaling is initiated by receptor-ligand interaction that elicits two consecutive proteolytic cleavages, S2 (Mumm et al., 2000) and S3 (Schroeter et al., 1998) , mediated by the metalloproteases of the ADAM family (Brou et al., 2000) and a g-sectreatese complex (De Strooper et al., 1999) , respectively. The last cleavage liberates the intracellular domain of Notch (NIC), which translocates to the nucleus (Struhl and Adachi, 1998) . Once in the nucleus, NIC associates with the DNA binding protein CSL/ RBPJj (Fortini and Artavanis-Tsakonas, 1994; Jarriault et al., 1995) thereby recruiting other coactivators and initiates the formation of a functional transcription activation complex driving target gene expression (Kurooka and Honjo, 2000; Oswald et al., 2001; Wallberg et al., 2002; Wu et al., 2000) .
The role of Notch signaling is known to be highly context-dependent and the molecular factors that deter-mine the final outcome of Notch signaling in a particular cell type or tissue remain to be fully elucidated. This gap in knowledge is in part due to the inability to identify cell populations receiving an active Notch signal in vivo. Several reporter mice have been generated to address this issue (Basak and Taylor, 2007; Duncan et al., 2005; Fre et al., 2011; Imayoshi et al., 2010; Ohtsuka et al., 2006; Souilhol et al., 2006; Vooijs et al., 2007) ; however, all of them have certain limitations. Some strategies aim to visualize endogenous Notch receptor activity, in which reporter expression is driven by promoter regions of the Notch target genes Hes1 or Hes5 (Basak and Taylor, 2007; Fre et al., 2011; Imayoshi et al., 2010; Ohtsuka et al., 2006) , or by multimerized RBPJj-binding sites (Duncan et al., 2005; Souilhol et al., 2006) . Nevertheless, Hes reporters can become activated by alternative signaling pathways and thus are not restricted to Notch-specific activation. The transgenic reporter mouse based on multimerized RBP-jj binding sites is Notch specific, but it is unclear through which of the four receptors the signal is initiated. Notch receptor-specific reporter lines have indeed been generated either by replacing the cytoplasmic domain of Notch1 with a cDNA coding for the cre recombinase (Vooijs et al., 2007) or by knocking in a Cre-ERT2 gene into the ATG of the different Notch receptors (Fre et al., 2011) . Although receptor specific, these systems do not discriminate between cells that receive an active Notch signal and cells descending from a Notch signaling precursor. The reporter systems based on expression of Cre-ERT2 from different Notch loci reflect Notch receptor expression but not necessarily signaling.
Here, we report the generation of an alternative reporter system designed to detect cells receiving an active Notch1 signal in vivo. The strategy is based on the generation of a chimeric Notch1 receptor, in which NIC is replaced by GAL4-VP16 (N1-Gal4VP16). The Notch1-specific proteolytic cleavage sites necessary for ligand-induced activation are preserved in this chimeric receptor (Fig. 1a) . The functionality of the N1-Gal4VP16 protein was initially confirmed in a coculture assay (Fig. 1b) , indicating that mechanistically the liganddependent activation of N1-Gal4VP16 is identical to endogenous Notch1 receptor activation.
As Notch1 signaling is dose dependent, we did not want to interfere with the endogenous Notch1 locus through gene targeting. Therefore, to ensure that the in vivo expression of N1-Gal4VP16 mirrored that of endogenous Notch1, we opted for a transgenic approach using a bacterial artificial chromosome (BAC) spanning a region 125 kb upstream and 30 kb downstream of the first and last coding exon of Notch1, respectively. We inserted the coding sequence for N1-Gal4VP16 into the BAC at the start codon present in the first coding exon of Notch1 via homologous recombination (Fig. 1c) (Gong et al., 2002; Sparwasser et al., 2004) . Correct targeting of the BAC was verified by PCR and Southern blot analysis (data not shown, and Fig. 1d ). The modified BAC was injected into the pronucleus of fertilized FVB/N zygotes and implanted into pseudopregnant females. Six out of 114 mice obtained, which all appeared phenotypically normal, were germline transmitters, but only 2 founder lines expressed detectable levels of N1-Gal4VP16 mRNA in thymocytes (data not shown).
We further characterized these two N1-Gal4VP16 founders by crossing them with a UAS-LacZ transgenic mouse line carrying a LacZ reporter gene under the control of a promoter containing six Gal4 binding sites (Govindarajan et al., 2005) . Consequently, in doubletransgenic (DBL-Tg) mice, ligand-specific activation of the chimeric Notch1 receptor results in the release of the GAL4-VP16 protein, which translocates into the nucleus resulting in LacZ reporter activation (Fig. 1a) .
Notch1 signaling is essential for the normal development of multiple organs during embryogenesis. At embryonic day (E) 13.5 we observe a widespread, but specific b-galactosidase staining in DBL-Tg embryos (Fig.  2a ,c-k), but not in UAS-LacZ littermates (Fig. 2b ). In the developing central nervous system (CNS), LacZ-activity was predominantly detected in the medulla oblongata, the pons (Fig. 2c ) and in the spinal cord (Fig. 2d) . It has been reported that segmentation of the somites depends on active Notch1 signaling (Conlon et al., 1995) . Accordingly, N1-Gal4VP16/UAS-LacZ mice revealed b-galactosidase expression in the clefts between the growing somites (Fig. 2d) . Proteolytic cleavage of the N1-Gal4VP16 transgene was also detected in the developing heart at E13.5 (Fig. 2e) . Notch1 signaling was shown to be important for digit formation and to be expressed at the apical ectodermal ridge (AER) from E10.5 onwards (Francis et al., 2005) . Concurrent with this report, N1-Gal4VP16 activity in the AER was observed at E10.5 (Fig. 2f ), E12.5 (Fig. 2g) , and E13.5 (Fig. 2h) . Moreover, Notch1 activation is crucial for the formation of the vasculature during embryogenesis (Krebs et al., 2000) . In agreement with these findings, we show that maturing blood vessels in double transgenic mice at E18.5 positively stain for b-galactosidase, presented by blood vessels at the surface of the brain ( Fig. 2i ) and in the dermis (Fig. 2j,k) . Costaining with the endothelial cell marker CD31 and X-Gal confirms that N1-GALVP16 driven reporter activity was restricted to endothelial cells (Fig. 2k) .
Analysis of X-Gal stained adult back skin and vibrissae established that N1-GalVp16 is continuously active in the sebaceous glands (SG) of hair follicles (HFs) and vibrissae ( Fig. 3a-g ). N1GalVp16 activity in the inner root sheet and the differentiating cells above the line of Auber (Au) was observed only during anagen phase of the hair cycle (Fig. 3a ,e,f). In addition, during telogen and early anagen HFs exhibit LacZ-staining in the isthmus (Fig. 3c,d ). Moreover, in both anagen and catagen FIG. 1. Generation of the N1-Gal4VP16 mouse founder lines. (a) Outline of the protein structure and the signaling pathway of the endogenous Notch1 receptor (top) and the modified receptor, N1-Gal4VP16 (bottom). The Notch1 receptor is presented on the cell surface as a heterodimer. The engagement of the Notch1 extracellular domain with its ligand triggers two consecutive proteolytic cleavages, S2 and S3, which leads to the release of the Notch intracellular domain (NIC). In the nucleus, NIC forms a binary complex with RBPjj, which recruits coactivators (CoA) to form the transcription-activating complex. In our model system, the NIC was replaced by the highly potent transcription factor Gal4-VP16. The shift from Notch1 to Gal4VP16 is at Arg1752, and consequently S2 and S3 are preserved in the fusion protein. Hence, interaction between an endogenous Notch ligand and the chimeric N1-Gal4VP16 receptor results in the proteolytic cleavage of the receptor followed by translocation of the Gal4VP16 protein into the nucleus, where it activates the expression of a Gal4-dependent LacZ reporter gene. EGF, epidermal growth factor-like repeats; LNR, Lin-Notch repeats; RAM, ram domain; ANK, ankyrin repeats; TAD, transactivation domain; PEST, PEST domain. (b) Functional assessment of the N1-Gal4VP16 construct in vitro. Relative luciferase activity was detected in HeLa cells transiently transfected with a reporter plasmid under the control of five Gal4 binding sites (pFRLuc), along with pBluescript or a N1-Gal4VP16 expression plasmid. Twelve hours after transfection, cells were cocultured for 24 h with HeLa cells expressing the Notch ligand Delta-like4 (DL4), with or without the g-secretase inhibitor DAPT (10 lM), as indicated. Data shown is a representative of three transfection experiments normalized to the internal TK-Renilla control. Reporter activities obtained upon cotransfecting pBluescript and pFRLuc were normalized to one, and error bars indicate SD. (c) Illustration of the strategy to generate the modified BAC integrated with the N1-Gal4VP16 cassette into the ATG of the mouse Notch1 gene. The shuttle vector contained a targeting construct of a 6.5 kb N1-Gal4VP16 sequence flanked by a 1.1 kb 5 0 and 1.2 kb 3 0 arm of homology, respectively. The modified BAC, shown at the bottom, is a product of homologous recombination between the wt BAC and the shuttle vector. Transgenic mouse lines were established by injections of the modified BAC into the pronuclei of fertilized FVB/N oocytes. Notch1 exon 1 and 2 are shown as light blue and blue squares, respectively, the Notch1 extracellular domain in light gray, Gal4VP16 in green, and the BGH polyA tail in white. (d) Southern-blot analysis of N1-Gal4VP16 transgenic founder lines. Genomic DNA was digested SalI/EcoRV and hybridized with 32 P-labelled PCR-products corresponding to the 3 0 -homologous arm or Gal4VP16 as indicated. The blot shows the N1-Gal4VP16 (12.2 kb) transgenic band for two N1-Gal4VP16 founder lines (26240 and 27075). The 5.7 kb band corresponds to the wt Notch1 alleles.
whiskers the differentiated cells, but not the basally located stem cells in the bulge region, stained positive for N1-GALVP16 driven b-galactosidase activity (Fig.   3f,g ). The timing of hair morphogenesis and of the first hair cycle in the DBL-Tg mice was identical to control animals (data not shown) (Alonso and Fuchs, 2006;  FIG. 3. N1-Gal4VP16 activity reflects active Notch1 signaling in the hair follicle. (a-e) Cross-sections of whole mount X-Gal stained backskin of N1-Gal4VP16 mice at (a) p14 (anagen), (b) p18 (catagen), (c) p20 (telogen), (d, e) p24 and p26 (first postnatal anagen). (f, g) Crosssection of whole mount X-Gal stained vibrissae in (f) anagen and (g) catagen phase. (h-j) X-Gal stained backskin 0, 3, and 10 days following dermabrasion. (k-m) Cross-section of X-Gal stained N1-Gal4VP16/UAS-LacZ skin from (k) the snout region and (l, m) the footpad. Nuclei are counterstained with nuclear fast red, and appear pink. Scale bars 5 100 lm or as indicated. IRS, inner root sheath; SG, sebaceous gland; Bu, bulge; DP, dermal papilla; Ist, isthmus; Inf, infundibulum, CH, club hair, Au, line of Auber; ORS, outer root sheet. Paus and Foitzik, 2004) . Dermabrasion studies performed on DBL-Tg mice suggest that Notch1 signalreceiving cells contribute to the regeneration of HFs and epidermis (Fig. 3h-j) . HFs from the snout area display b-galactosidase positive cells in the SG, outer root sheet, and the bulge (Fig. 3k) . Units of N1-GalVP16 activity were also detected in the footpad (Fig. 3l) , with sporadic staining in the basal layer (Fig. 3m) .
X-Gal staining of intestinal segments from DBL-Tg animals indicates that Notch1 activity is restricted to the intestinal crypts in the duodenum (Fig. 4a) , as well as in the jejunum and ileum (data not shown). Notch1 signaling has been proposed to be active in crypt progenitors and in Lgr5 1 stem cells at the bottom of the intestinal crypt (Pellegrinet et al., 2011) . Indeed, cells at the crypt base of the DBL-Tg mice revealed b-galactosidase staining in crypt progenitors and in intestinal stem cells wedged between the Paneth cells (Fig. 4b,c) . This notion was further confirmed upon costaining with the Paneth cell marker lysozyme (Fig. 4e) . Staining of wild type duodenum for cleaved Notch1 using the Val1744 antibody established that the N1-GalVP16 activity is indeed representative for Notch1 activation in the intestine (Fig. 4d) . In addition, LacZ-activity was observed in the colon at the crypt base as well as in the proliferative compartment (Fig. 4f) . To further confirm the in vivo gsecretase-dependent activation of the N1-GALVP16 fusion protein, DBL-Tg mice were treated with the gsecretase inhibitor dibenzazepine (DBZ). The absence of LacZ-positive cells accompanied with goblet cell metaplasia in the small intestine indicated a complete block of endogenous Notch signaling as well as N1-Gal4VP16 activity (Fig. 4g,h ), which is in agreement with previous reports (Pellegrinet et al., 2011) .
Reproductive organs revealed specific LacZ-staining in the pseudostratified columnar epithelial cells of the epididymis wall (Fig. 5a ) and in the uterine glands (Fig. 5b) . Notch1-activity was not observed in the testis or mature spermatozoa (data not shown). In the mammary gland from a lactating female, scattered luminal epithelial cells were LacZ-positive (Fig. 5c) , while no N1-Gal4VP16-activity was observed in the mammary glands from virgin females (data not shown).
In the adult brain, Notch1 reporter activity was most distinct in the lateral ventricles (LV), but also present in astrocytes (Fig. 6a,c) . No LacZ-positive cells were detected in the brain of UAS-LacZ littermate control animals (Fig. 6b) . Staining of wild type brain with the anti-Val1744 antibody confirms that endogenous Notch1 activity is mirrored by the pattern of reporter activity (Fig. 6d) . This is in agreement with data from Carlén et al., stating that ependymal cells lining the LV wall receive active Notch1 signals (Carlen et al., 2009) .
Taken together, the N1-Gal4VP16 activity observed in our BAC-transgenic reporter mice correlates well with the expected profile of active Notch1 signaling based on established knowledge and antibody staining assays. Thus, we conclude that the activation of the N1-Gal4VP16 is consistent with the activity of the endogenous Notch1 receptor. Moreover, this reporter mouse is a powerful tool, which enables the visualization of active Notch1 signaling in embryonic and post-natal development in vivo.
MATERIAL AND METHODS

Mice
The N1-Gal4VP16 targeting vector was generated by replacing the intracellular domain of the Notch1 receptor with a cDNA fragment encoding for Gal4VP16. Furthermore, a 1.1 kb and a 1.2 kb fragment immediately upstream and downstream of the endogenous Notch1 ATG were amplified by PCR (688C, 30 cycles) using primer pairs #1 (5 0 -TTACGAACGCGTGGCGCGC-CAACTCTGCACTTTCCCAGGCCACCTAAG-3 0 ) and #2 (5 0 -TACTCCAAGCTTGCCTGCTCGCCAGCTGCCCGCAG CC-3 0 ), #3 (5 0 -TTACGAACCGGTCCACGGCTCCTGACG CCCTTGCTCT-3 0 ), and #4 (5 0 -TACTCCTTAATTAAGTT-CAAACACAAGATACGAGGGGACCG-3 0 ) and a BAC clone (RP23-412O13, CHORI BACPAC Resources Center, Oakland, CA) encoding the complete mouse Notch1 gene locus as a template. The purified PCR fragments were cloned upstream of the N1-Gal4VP16 ATG, and downstream of the cDNA3.1 bovine growth hormone (BGH) polyA tail. The whole recombination cassette, N1-Gal4VP16 including the homologous arms, was transferred to the shuttle vector pLD53.SC-AB (Gong et al., 2002; Metcalf et al., 1996) (kindly received from Dr. Gerard Eberl) and inserted into the site of the Notch1 ATG in the wild-type BAC, via a two-step homologous recombination as previously described (Gong et al., 2002; Sparwasser et al., 2004) . Briefly, the shuttle vector carrying the N1-Gal4VP16 recombination cassette was electroporated into the BAC-containing bacteria (DH10B RecA 2 cells), and selected on Luria broth (LB) agar plates containing chloramphenicol (12.5 lg/ml) and ampicillin (50 lg/ml). Successful integration of the shuttle vector into the BAC was confirmed by PCR using the following primer pairs: #5 (5 0 -AAAGGGA-TAAGGAAGGCATCTTGGACGC-3 0 ) and #6 (5 0 -AGTAGCTTGTATTCTATAGTGTCACC-3 0 ), or #7 (5 0 -TAGGGTGATGGTTCACGTAGTGCG-3 0 ) and #8 (5 0 -ACA-CAGCCAAAGTGGGAGGGGATTAAGG-3 0 ). Colonies positive for double integration were selected again on LB-agar plates containing chloramphenicol (12.5 lg/ml) and sucrose (5%). Resolved and modified BAC clones were identified by PCR with primer pairs listed above, and by Southern blot analysis using a 32 P-labeled probe specific for the 3 0 homologous arm (for details see below). The modified BAC DNA was purified and injected into pronuclei of fertilized FVB/N zygotes. Offspring was typed for the presence of the N1-Gal4VP16 transgene using the following primers pairs: #9 (5 0 -CTAGGTGCTCTTGCGTCACTTGGC-3 0 ) and #10 (5 0 -CTCCACTGAAGCCAATCTATCTGTG-3 0 ). Founder lines typed positive for the transgene N1-Gal4VP16 by PCR were also verified by Southern blot analysis (see details below). Heterozygous N1-Gal4VP16 mice were subsequently crossed with the UAS-lacZ transgenic reporter mice, kindly provided by Dr. P. Overbeek, Houston (Govindarajan et al., 2005) .
The UAS-lacZ mice were genotyped with primers specific for the lacZ gene: #11 (5 0 -CCCATTACGGTCAA TCCGCCG-3 0 ) and #12 (5 0 -GCCTCCAGTACAGCGCG GCTG-3 0 ). Details for individual PCR reactions will be provided upon request. This transgenic Notch1 signaling specific reporter mouse line will be available to the research community upon acceptance of the manuscript.
The g-secretase inhibitor DBZ (25 lM/kg body weight in dimethyl sulfoxide (DMSO); Calbiochem, San Diego, CA) was injected intraperitoneally for four consecutive days. Mice were analyzed 24 h after the last injection.
Ethics Statement
All animal work was conducted according to Swiss national guidelines and under EPFL animal care regulations. They were housed in individual cages at (23 6 1)8C with a 12 h light/dark cycle. All animals were supplied with food and water ad libitum. This study has been reviewed and approved by the Service Vétérinaire Cantonal of Etat de Vaud. 
Southern Blot Hybridization
Southern blot hybridizations were performed following standard procedures. Briefly, 20 lg of BAC or genomic tail DNA were digested with SalI/EcoRV restriction enzymes and resolved in an 0.8% agarose gel. Digested DNA was transferred onto a Hybond-N1 nylon membrane (GE Healthcare Life Sciences, Buckinghamshire, UK) and hybridized overnight at 658C with either a 32 P-labelled PCR product corresponding to the 3 0 -homologous arm or a 32 P-labelled 700 bp Gal4VP16 fragment amplified using the following primers: #13 (5 0 -GCGCATGAAGCTACTGTCTTCTA TCG-3 0 ) and #14 (5 0 -GCTACCCACCGTACTCGTCAA TTCC-3 0 ). Positive labeled N1-Gal4VP16 transgenic samples were visualized using a Phosphorimager (FLA3000; Fujifilm).
Tissue Culture Conditions, Transfections, and Luciferase assays
HeLa cells were cultured at 378C and 5% CO 2 in Dulbecco's Modified Eagle's Medium (DMEM) (high glucose, GlutaMAX 2 -I) medium supplemented with 10% fetal calf sreum (FCS) and 0.1 mg/ml Penicillin/Streptomycin (all purchased from Gibco 1 , Invitrogen Corporation, Paisley, UK). HeLa cells seeded into a 12-well tissue culture plate were transiently transfected with 2 lg of a DL4 expression plasmid, or 1 lg pFR-Luc (Stratagene, Offenbach, Germany) and 50 ng of prL-TK (Promega Corporation, Madison, WI) reporter plasmids, along with 1 lg pBluescript (Stratagene, Offenbach, Germany) and the N1-Gal4VP16 expression plasmid using the transfection reagent JetPEI 2 (PolyPlus Transfection, Illkirch, France) according to the manufacturer's recommendations. In order to induce N1-GAL4VP16 driven activation of the reporter gene, N1-GAL4VP16 expressing cells were cocultured with DL4 expressing HeLa cells in a 1:1 ratio in the presence or absence of 10 lM DAPT (Merck & Co., New Jersey, USA). Twenty-four hour post-coculture, cells were lysed using 250 ll of passive lysis buffer and the luciferase assay was performed with a Dual-Luciferase 2 Reporter Assay System (Promega Corporation, Madison, WI) using 20 ll of the total protein extract. All samples were analyzed in triplicates.
X-Gal Staining
Whole mount embryos (10.5-14.5 dpc) as well as dissected whole mount organs (18.5 dpc to adult mice) were fixed at 48C in LacZ fixative (0.2% glutaraldehyde, 5 mM EGTA (pH 7.3) and 4 mM MgCl 2 in 0.1M sodium phosphate buffer (pH 7.3)), washed three times in detergent wash (2 mM MgCl 2 , 0.01% desoxycholate, and 0.02% NP40 in 0.1 M sodium phosphate buffer (pH 7.3)), and stained for b-galactosidase activity for 2-24 h at 378C in detergent wash supplemented with 0.66 mg/ ml X-Gal, 3.33 mM K 3 Fe(CN) 6 , 3.33 mM K 4 Fe(CN) 6 , and 20 mM Tris-HCl (pH 7.3). Subsequently, the embryos and organs were rinsed in 13 PBS and postfixed for 1-3 h in 4% paraformaldehyde (PFA). Embryos were photographed as whole mount, or embedded in 5% agarose in 13 phosphate buffered saline (PBS) and sectioned at 500 lm using a vibratome. For histology, whole mount stained tissues were dehydrated, paraffin embedded, sectioned at 4 lm, and counterstained with Nuclear Fast Red according to standard procedures. X-Gal stained whiskers and intestine were embedded in optimal cutting temrature (OCT) tissue matrix and processed as described above. b-Galactosidase activity in the adult brain of transgenic mice was visualized after transcardial perfusion using 4% PFA. Brains were postfixed for 1 h at 48C in 4% PFA, cryoprotected in 30% sucrose over night, embedded in OCT, cut in 35 lm free floating coronal sections, and stained as described above.
Immunohistochemistry
Immunofluorescent costaining for CD31 and b-galactosidase were done on sections (6 lm) of fresh frozen skin. The sections were fixed in methanol, blocked in 1% bovine serum albumine (BSA), and stained at 48C overnight with the following primary antibodies; monoclonal rat anti-mouse CD31 (1:100 dilution; BD Pharmingen, BD biosciences, San Jose, CA) and polyclonal goat anti-b-galactosidase (1:150 dilution; Biogenesis, AbD Serotac, Oxon, UK). Alexa Fluor 568 goat anti-rat IgG (dilution 1/1000; Molecular Probes, Life Technologies Corporation), and Alexa Fluor 488 donkey anti-goat IgG (dilution 1/800; Molecular Probes, Life Technologies, Carlsbad, CA) were used as secondary antibodies, and nuclei counterstained with DAPI. Lysozyme staining was performed on paraffin sections of whole mount XGal stained intestinal samples. Sections were dewaxed, rehydrated, pretreated with peroxidase (5 min, 3% H 2 O 2 ), antigen retrieved (20 min at 958C in 10 mM sodium citrate buffer pH 6.0), and stained with a rabbit anti-lysozyme antibody (1:500 dilution overnight at 48C; DAKO, Glostrup, Denmark). HRP-labeled anti-rabbit antibody was used for second stage staining and the chromogen-substrate was detected with DAB revelation (Sigma, St. Louis, MO). Sections from whole mount XGal stained intestine DBZ-treated mice were stained using the Periodic acid-Schiff (PAS) technique and counterstained with Mayer's Hematoxylin. Cleaved Notch1 was detected on sections of 4% PFA-fixed paraffin embedded wild type intestine. Antigen retrieval was performed in DIVA decloaker buffer (Biocare medical, Concord, CA) and sections were incubated with a primary rabbit polyclonal antibody raised against cleaved Notch1 Val1744 (1:300 dilution overnight at 48C; Abcam, Cambridge, UK). Sections were then incubated with horseradish peroxidase (HRP) labeled polymers conjugated to goat anti-rabbit immunoglobulins (EnVision+ System, DAKO, Glostrup, Denmark) and the staining was visualized with DAB revelation (Sigma, St. Louis, MO). Cleaved Notch1 in the brain was revealed on 35 lm free floating sections of wild type mice perfused with 4% PFA. Sections were treated with 1N HCl for 30 min at 658C, quenched for 15 min at RT [3% H 2 O 2 and 10% methanol in 0.1 M potassium phosphate buffered saline (KPBS)] and incubated for 1 h in blocking solution (5% normal serum and 0.25% Triton-X in KPBS). Subsequently, sections were stained with a primary antibody directed against cleaved Notch1 Val1744 (1:200 dilution in blocking solution overnight at RT; Abcam, Cambridge, UK). A biotinylated goat anti-rabbit IgG secondary antibody (Vector Laboratories, Burlingame, CA) was then applied for 1 h at RT. Antibody binding was visualized using the Vectastain ABC kit (Vector Laboratories, Burlingame, CA) and DAB-revelation.
